Danaher Corporation $DHR Shares Purchased by Union Bancaire Privee UBP SA

Posted by on Jun 27th, 2026

Union Bancaire Privee UBP SA raised its position in Danaher Corporation (NYSE:DHR – Free Report) by 116.7% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 142,263 shares of the conglomerate’s stock after buying an additional 76,601 shares during the quarter. Union Bancaire Privee UBP SA’s holdings in Danaher were worth $25,078,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Elevated Capital Advisors LLC purchased a new position in shares of Danaher in the 4th quarter valued at about $26,000. Hilton Head Capital Partners LLC acquired a new position in Danaher during the fourth quarter worth about $27,000. Clal Insurance Enterprises Holdings Ltd lifted its holdings in shares of Danaher by 71.6% in the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock valued at $29,000 after purchasing an additional 53 shares in the last quarter. JPL Wealth Management LLC acquired a new stake in shares of Danaher in the third quarter valued at approximately $25,000. Finally, WFA of San Diego LLC purchased a new position in shares of Danaher during the 2nd quarter worth approximately $26,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Performance

NYSE DHR opened at $195.67 on Friday. The business’s 50-day simple moving average is $178.81 and its 200-day simple moving average is $201.69. The firm has a market capitalization of $138.49 billion, a P/E ratio of 37.85, a P/E/G ratio of 2.46 and a beta of 0.81. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52.

Danaher (NYSE:DHR – Get Free Report) last announced its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. The firm had revenue of $5.95 billion during the quarter, compared to analysts’ expectations of $6 billion. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The firm’s revenue was up 3.7% on a year-over-year basis. During the same period in the prior year, the company earned $1.88 EPS. Equities analysts predict that Danaher Corporation will post 8.44 EPS for the current year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be issued a $0.40 dividend. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a yield of 0.8%. Danaher’s dividend payout ratio (DPR) is currently 30.95%.

Analyst Ratings Changes

A number of equities research analysts have commented on the company. Argus lowered their target price on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a report on Friday, April 24th. Rothschild & Co Redburn set a $205.00 price objective on Danaher in a research note on Friday, April 17th. The Goldman Sachs Group cut their target price on shares of Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research note on Monday, April 13th. Guggenheim lowered their price target on shares of Danaher from $275.00 to $235.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. Finally, Wolfe Research lowered shares of Danaher from an “outperform” rating to a “peer perform” rating in a research report on Monday, June 1st. One research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $233.61.

Check Out Our Latest Research Report on DHR

About Danaher

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Read More

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.